The 2016 Bon Secours Cancer Summit on Friday, September 30 at the Marriott Hotel in Glen Allen, Virginia, will offer state-of-the-art knowledge on advances in oncology screening, treatment, and survivorship. This Summit, presented by the Bon Secours Cancer Institute of Virginia, will feature invited speakers on subjects including genetics, clinical trials, stereotactic and brachytherapy, personalized medicine, integrative medicine, obesity and cancer.
Primary care physicians, specialists, OB-GYNs, surgeons, medical oncologists, radiation oncologists, nurse practitioners and other healthcare professionals interested in a deeper knowledge and understanding of the full continuum of cancer care including healthy survivorship.
Participants at the end of the summit will be able to:
--Discuss an introduction to the role of integrative medicine in oncology
--Describe the evolving role of genetics and genetic testing in cancer and in public health and the role of the primary care physician in this field
--Elaborate the importance of clinical trials for the future of cancer therapy
--Discuss the implications of precision/personalized medicine in oncology
--Articulate the basics of screening mammography for the oncologist and primary care physician
--Discuss the importance of cancer survivorship through the experience of a survivor
--Discuss novel concepts in treating obesity to prevent and treat cancer
--Explain the latest techniques in radiation oncology
Accreditation and Designation Statement
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Virginia School of Medicine and Bon Secours Cancer Institute.
The University of Virginia School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
The University of Virginia School of Medicine designates this live activity for a maximum of 5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The University of Virginia School of Medicine awards hours of participation (equivalent to AMA PRA Category 1 Credit(s)™)to each non-physician participant who successfully completes this educational activity. Bon Secours Cancer Institute maintains a permanent record of participants who have been awarded CEUs
Disclosure of Faculty Financial Affiliations
The University of Virginia School of Medicine, as an ACCME accredited provider, endorses and strives to comply with the Accreditation Council for Continuing
Medical Education (ACCME) Standards of Commercial Support, Commonwealth of Virginia statutes, University of Virginia policies and procedures, and associated federal and private regulations and guidelines on the need for disclosure and monitoring of proprietary and financial interests that may affect the scientific integrity and balance of content delivered in continuing medical education activities under our auspices.
The University of Virginia School of Medicine requires that all CME activities accredited through this institution be developed independently and be scientifically rigorous, balanced and objective in the presentation/discussion of its content, theories and practices.
All faculty presenters participating in an accredited CME activity are expected to disclose relevant financial relationships with commercial entities occurring within the past 12 months (such as grants or research support, employee, consultant, stock holder, member of speakers bureau, etc.).
The University of Virginia School of Medicine will employ appropriate mechanisms to resolve potential conflicts of interest to maintain the standards of fair and balanced education to the participant. Questions about specific strategies can be directed to the Office of Continuing Medical Education, University of Virginia School of Medicine, Charlottesville, Virginia. DISCLOSURE OF DISCUSSION OF NON FDA-APPROVED USES FOR PHARMACEUTICAL PRODUCTS AND/OR MEDICAL DEVICES
The following faculty and staff have reported an affiliation to disclose:
- Eliseo A. Bautista, MD, FACS-the following faculty has disclosed relevant financial relationship as a surgeon proctor with Intuitive Surgical Inc.; the following faculty has disclosed they are a consultant with Covidien.
- Howard McLeod, PharmD–the following faculty has disclosed stock/ownership with Cancer Genetics Inc.
- James V. Pellicane, MD—the following faculty has disclosed Speakers Bureau, Faculty, Peer Reviewer for Agendia; the following faculty has disclosed Speakers Bureau, Faculty, Peer Reviewer for Focal Therapeutics; the following faculty has disclosed Speakers Bureau, Faculty, Peer Reviewer for Dune Medical.
- Christian Shields, MD– the following faculty have disclosed relevant financial relationship of real estate with Patient First Corporation.
The following faculty has disclosed no financial relationship or interest with any propriety entity producing healthcare goods or services.
- Marylou S. Anton, MSN, RN, OCN*
- James P. Evans, MD, PhD
- Judy H. Heilman, MBA*
- William Irvin, Jr., MD
- Elizabeth M. Kelley*
- Catherine Lantz, MS, RN, AOCNS*
- Geralyn Lucas
- Lauralee McFarland*
- George Parker, MD*
- Bradley Prestidge, MD, MS
- Susan W. Schaffer, DO
- Leigh T. Sewell*
*denotes Planning Committee
The University of Virginia School of Medicine, as an ACCME provider, requires that all faculty presenters identify and disclose any off-label uses for pharmaceutical and medical device products. The University of Virginia School of Medicine recommends that each physician fully review all the available data on new products or procedures prior to clinical use.
The University of Virginia Office of Continuing Medical Education requires that all participants at live CME activities sign attendance sheets daily to confirm participation in the CME activity for that day.